JESSICA SANFORD: Open Payments
NPI 1295456184 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 83 payments from 17 companies in 2025. Trend: 2023 $700 · 2024 $608 · 2025 $1,453
Food & beverage: $1,453
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $283 |
| Janssen Biotech, Inc. | 15 | $194 |
| ABBVIE INC. | 12 | $183 |
| Amgen Inc. | 11 | $150 |
| Lilly USA, LLC | 6 | $113 |
| E.R. Squibb & Sons, L.L.C. | 5 | $98 |
| LEO Pharma Inc. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Galderma Laboratories, L.P. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
Products named: Bimzelx, TREMFYA, SKYRIZI, OTEZLA, Sotyktu, TALTZ, ADBRY, NEMLUVIO.
Industry payments across TX — which companies pay providers there.
